John Townsend - 15 Apr 2024 Form 4 Insider Report for Unicycive Therapeutics, Inc. (UNCY)

Role
Chief Financial Officer
Signature
/s/ John Townsend
Issuer symbol
UNCY
Transactions as of
15 Apr 2024
Net transactions value
$0
Form type
4
Filing time
17 Apr 2024, 16:33:14 UTC
Previous filing
30 Aug 2023
Next filing
14 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UNCY Stock Options Award $0 +228,119 +35% $0.000000 875,309 15 Apr 2024 Common Stock 228,119 $1.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 57,030 of the stock options vest on the first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter.